Piper Sandler reaffirmed its Overweight rating on DexCom (NASDAQ:DXCM) stock, maintaining a price target of $90.00. The firm's analysts highlighted several positive developments for the medical device ...
Piper Sandler analyst Michael Lavery maintained a Hold rating on The Hershey Company (HSY – Research Report) today and set a price target of ...